| MODERNA INC. DL-,0001 |
| USA |
| Gesundheit |
| US60770K1079 / A2N9D9 |
| 0QF (Frankfurt) / MRNA (NASDAQ) |
| FRA:0QF, ETR:0QF, 0QF:GR, NASDAQ:MRNA |
| S&P500 |
| https://www.modernatx.com.. |
|
Moderna, Inc. is a biotechnology company focused on messenger RNA (mRNA) medicines and vaccines. Its portfolio centers on products for respiratory and infectious diseases, including COVID-19 and RSV vaccines, alongside a pipeline that extends into on..
>Volltext.. |
| 20437.59 Mio. EUR |
| 17076.78 Mio. EUR |
| 1927.59 Mio. EUR |
| -2663.84 Mio. EUR |
| -2726.13 Mio. EUR |
| -6.91 EUR |
| 1113.47 Mio. EUR |
| 1490.68 Mio. EUR |
| -928.32 Mio. EUR |
| 2.03 |
| -25.34% |
| -11.96% |
| - |
| - |
| - |
| 2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 28.001.564 Euro. |
| MODERNA |
| 11.08.26 |
|